Cardiol Therapeutics Class Stock Price on October 9, 2024
| CRDL Stock | CAD 2.26 0.05 2.16% |
Below is the normalized historical share price chart for Cardiol Therapeutics Class extending back to December 20, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cardiol Therapeutics stands at 2.26, as last reported on the 29th of November, with the highest price reaching 2.30 and the lowest price hitting 2.19 during the day.
If you're considering investing in Cardiol Stock, it is important to understand the factors that can impact its price. Cardiol Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0343, which signifies that the company had a -0.0343% return per unit of risk over the last 3 months. Cardiol Therapeutics Class exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cardiol Therapeutics' Risk Adjusted Performance of (0.01), standard deviation of 3.83, and Mean Deviation of 2.85 to double-check the risk estimate we provide.
At this time, Cardiol Therapeutics' Total Stockholder Equity is very stable compared to the past year. As of the 29th of November 2024, Liabilities And Stockholders Equity is likely to grow to about 38.6 M, while Common Stock Total Equity is likely to drop about 36.4 M. . As of the 29th of November 2024, Price To Sales Ratio is likely to drop to 1,023. In addition to that, Price Earnings Ratio is likely to drop to -2.65. Cardiol Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 2.6877 | 50 Day MA 2.6267 | Beta 0.697 |
Cardiol |
Sharpe Ratio = -0.0343
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CRDL |
Estimated Market Risk
| 3.93 actual daily | 34 66% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cardiol Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardiol Therapeutics by adding Cardiol Therapeutics to a well-diversified portfolio.
Price Book 18.0709 | Enterprise Value Ebitda 0.4057 | Price Sales 1.3 K | Shares Float 66.6 M | Wall Street Target Price 11 |
Cardiol Therapeutics Main Headline on 9th of October 2024
Cardiol Therapeutics Announces Pricing of Public Offering of... by news.google.com
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares CRDL Stock News StockTitan
Cardiol Therapeutics Valuation on October 9, 2024
It is possible to determine the worth of Cardiol Therapeutics on a given historical date. On October 9, 2024 Cardiol was worth 2.2 at the beginning of the trading date compared to the closed value of 2.53. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cardiol Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cardiol Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardiol Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cardiol Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.59 | 2.69 | 2.58 | 2.69 | 64,527 | |
10/09/2024 | 2.20 | 2.55 | 2.14 | 2.53 | 788,316 |
| 2.52 | 2.52 | 2.36 | 2.46 | 197,779 |
| Backtest Cardiol Therapeutics | | | Cardiol Therapeutics History | | | Cardiol Therapeutics Valuation | Previous | Next |
Cardiol Therapeutics Trading Date Momentum on October 9, 2024
| On October 10 2024 Cardiol Therapeutics Class was traded for 2.46 at the closing time. The highest price during the trading period was 2.52 and the lowest recorded bid was listed for 2.36 . The volume for the day was 197.8 K. This history from October 10, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 2.77% . The overall trading delta to the current price is 5.14% . |
Cardiol Therapeutics Fundamentals Correlations and Trends
By evaluating Cardiol Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cardiol Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cardiol financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cardiol Therapeutics Stock history
Cardiol Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardiol is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardiol Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardiol Therapeutics stock prices may prove useful in developing a viable investing in Cardiol Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 64.5 M | 41.5 M | |
| Net Loss | -27.8 M | -29.2 M |
Cardiol Therapeutics Quarterly Net Working Capital |
|
Cardiol Therapeutics Stock Technical Analysis
Cardiol Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cardiol Therapeutics Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Cardiol Therapeutics Class cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cardiol Therapeutics November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Cardiol Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiol Therapeutics shares will generate the highest return on investment. By undertsting and applying Cardiol Therapeutics stock market strength indicators, traders can identify Cardiol Therapeutics Class entry and exit signals to maximize returns
Cardiol Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cardiol Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cardiol Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardiol to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.